![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: OVOL1 |
Gene summary for OVOL1 |
![]() |
Gene information | Species | Human | Gene symbol | OVOL1 | Gene ID | 5017 |
Gene name | ovo like transcriptional repressor 1 | |
Gene Alias | HOVO1 | |
Cytomap | 11q13.1 | |
Gene Type | protein-coding | GO ID | GO:0000003 | UniProtAcc | O14753 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
5017 | OVOL1 | LZE8T | Human | Esophagus | ESCC | 3.47e-08 | 1.73e-01 | 0.067 |
5017 | OVOL1 | LZE20T | Human | Esophagus | ESCC | 1.18e-08 | 1.11e+00 | 0.0662 |
5017 | OVOL1 | LZE24T | Human | Esophagus | ESCC | 2.50e-03 | 5.96e-01 | 0.0596 |
5017 | OVOL1 | P1T-E | Human | Esophagus | ESCC | 9.30e-04 | 7.56e-01 | 0.0875 |
5017 | OVOL1 | P2T-E | Human | Esophagus | ESCC | 1.78e-04 | 3.65e-02 | 0.1177 |
5017 | OVOL1 | P4T-E | Human | Esophagus | ESCC | 4.20e-11 | 8.04e-01 | 0.1323 |
5017 | OVOL1 | P5T-E | Human | Esophagus | ESCC | 1.70e-06 | 3.42e-01 | 0.1327 |
5017 | OVOL1 | P8T-E | Human | Esophagus | ESCC | 4.27e-04 | 9.61e-02 | 0.0889 |
5017 | OVOL1 | P9T-E | Human | Esophagus | ESCC | 1.60e-03 | -5.03e-02 | 0.1131 |
5017 | OVOL1 | P11T-E | Human | Esophagus | ESCC | 1.81e-06 | 9.45e-01 | 0.1426 |
5017 | OVOL1 | P12T-E | Human | Esophagus | ESCC | 4.07e-10 | 5.58e-01 | 0.1122 |
5017 | OVOL1 | P20T-E | Human | Esophagus | ESCC | 2.45e-02 | 5.97e-01 | 0.1124 |
5017 | OVOL1 | P21T-E | Human | Esophagus | ESCC | 5.86e-11 | 6.91e-01 | 0.1617 |
5017 | OVOL1 | P22T-E | Human | Esophagus | ESCC | 7.63e-03 | 5.10e-02 | 0.1236 |
5017 | OVOL1 | P23T-E | Human | Esophagus | ESCC | 2.00e-08 | 9.42e-01 | 0.108 |
5017 | OVOL1 | P26T-E | Human | Esophagus | ESCC | 2.15e-15 | 4.28e-01 | 0.1276 |
5017 | OVOL1 | P27T-E | Human | Esophagus | ESCC | 4.00e-08 | 5.30e-01 | 0.1055 |
5017 | OVOL1 | P28T-E | Human | Esophagus | ESCC | 1.88e-54 | 1.66e+00 | 0.1149 |
5017 | OVOL1 | P31T-E | Human | Esophagus | ESCC | 1.21e-21 | 9.80e-01 | 0.1251 |
5017 | OVOL1 | P38T-E | Human | Esophagus | ESCC | 1.48e-03 | 3.47e-01 | 0.127 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000734615 | Esophagus | ESCC | regulation of mitotic cell cycle | 293/8552 | 457/18723 | 8.00e-16 | 5.64e-14 | 293 |
GO:190198713 | Esophagus | ESCC | regulation of cell cycle phase transition | 242/8552 | 390/18723 | 3.86e-11 | 1.26e-09 | 242 |
GO:00457865 | Esophagus | ESCC | negative regulation of cell cycle | 236/8552 | 385/18723 | 3.62e-10 | 9.93e-09 | 236 |
GO:004578710 | Esophagus | ESCC | positive regulation of cell cycle | 196/8552 | 313/18723 | 9.27e-10 | 2.24e-08 | 196 |
GO:00435888 | Esophagus | ESCC | skin development | 163/8552 | 263/18723 | 6.48e-08 | 1.14e-06 | 163 |
GO:000854410 | Esophagus | ESCC | epidermis development | 193/8552 | 324/18723 | 2.87e-07 | 4.19e-06 | 193 |
GO:00109484 | Esophagus | ESCC | negative regulation of cell cycle process | 177/8552 | 294/18723 | 3.26e-07 | 4.59e-06 | 177 |
GO:19019883 | Esophagus | ESCC | negative regulation of cell cycle phase transition | 151/8552 | 249/18723 | 1.28e-06 | 1.57e-05 | 151 |
GO:004593013 | Esophagus | ESCC | negative regulation of mitotic cell cycle | 143/8552 | 235/18723 | 1.84e-06 | 2.15e-05 | 143 |
GO:000991310 | Esophagus | ESCC | epidermal cell differentiation | 122/8552 | 202/18723 | 1.69e-05 | 1.51e-04 | 122 |
GO:00016559 | Esophagus | ESCC | urogenital system development | 177/8552 | 338/18723 | 7.51e-03 | 2.69e-02 | 177 |
GO:00073469 | Oral cavity | OSCC | regulation of mitotic cell cycle | 266/7305 | 457/18723 | 3.87e-17 | 3.41e-15 | 266 |
GO:19019875 | Oral cavity | OSCC | regulation of cell cycle phase transition | 209/7305 | 390/18723 | 2.79e-09 | 6.42e-08 | 209 |
GO:00457879 | Oral cavity | OSCC | positive regulation of cell cycle | 173/7305 | 313/18723 | 3.28e-09 | 7.44e-08 | 173 |
GO:00457864 | Oral cavity | OSCC | negative regulation of cell cycle | 206/7305 | 385/18723 | 4.28e-09 | 9.55e-08 | 206 |
GO:00459304 | Oral cavity | OSCC | negative regulation of mitotic cell cycle | 132/7305 | 235/18723 | 6.51e-08 | 1.16e-06 | 132 |
GO:00435887 | Oral cavity | OSCC | skin development | 143/7305 | 263/18723 | 2.77e-07 | 4.27e-06 | 143 |
GO:00085449 | Oral cavity | OSCC | epidermis development | 171/7305 | 324/18723 | 2.89e-07 | 4.43e-06 | 171 |
GO:19019882 | Oral cavity | OSCC | negative regulation of cell cycle phase transition | 136/7305 | 249/18723 | 3.81e-07 | 5.70e-06 | 136 |
GO:00109483 | Oral cavity | OSCC | negative regulation of cell cycle process | 155/7305 | 294/18723 | 1.11e-06 | 1.48e-05 | 155 |
Page: 1 2 3 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
OVOL1 | SNV | Missense_Mutation | rs781707967 | c.183N>C | p.Leu61Phe | p.L61F | O14753 | protein_coding | tolerated(0.08) | possibly_damaging(0.557) | TCGA-86-8358-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
OVOL1 | SNV | Missense_Mutation | rs779727157 | c.655N>A | p.Gly219Ser | p.G219S | O14753 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-90-7767-01 | Lung | lung squamous cell carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
OVOL1 | SNV | Missense_Mutation | novel | c.625N>T | p.Arg209Trp | p.R209W | O14753 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-CV-7568-01 | Oral cavity | head & neck squamous cell carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
OVOL1 | SNV | Missense_Mutation | novel | c.404N>A | p.Arg135His | p.R135H | O14753 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-CV-A6JT-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
OVOL1 | SNV | Missense_Mutation | rs151272806 | c.551N>T | p.Thr184Met | p.T184M | O14753 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-BR-8485-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
OVOL1 | SNV | Missense_Mutation | rs577150616 | c.427N>A | p.Val143Ile | p.V143I | O14753 | protein_coding | deleterious(0.04) | benign(0.061) | TCGA-CG-5721-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |